ESC 365 - Association of left ventricular ejection fraction improvement with prognosis in patients with cardiac sarcoidosis: insights from the ILLUMINATE-CS study

ESC Professional Premium Access

Association of left ventricular ejection fraction improvement with prognosis in patients with cardiac sarcoidosis: insights from the ILLUMINATE-CS study

Session: Cardiac amyloidosis, sarcoidosis, and inflammation

Topic: Ventricular Remodelling

Speaker: Doctor D. Maeda (Tokyo, JP)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Daichi Maeda

Juntendo University Graduate School of Medicine, Tokyo (Japan)

0 follower

8 more presentations in this session

Delays in diagnosis and treatment initiation of ATTR cardiac amyloidosis: a real-world data analysis

Speaker: Doctor J. Vogel (Essen, DE)

Transthyretin stabiliser therapy in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis

Speaker: Mr V. Ribeiro (Teresina, BR)

Prevalence of transthyretin amyloid cardiomyopathy in patients hospitalised for heart failure with preserved ejection fraction in an LATAM center.

Speaker: Mr S. Decotto (Buenos Aires, AR)

Biomarkers for monitoring patients with cardiac amyloidosis during transthyretin-stabilizer therapy

Speaker: Doctor J. Vogel (Essen, DE)

Relationship between changes in renal function after acute phase of tafamidis administration and left ventricular diastolic function at mid-term follow-up in transthyretin cardiac amyloidosis

Speaker: Ms A. Senda (Kobe, JP)

Access the full session

Cardiac amyloidosis, sarcoidosis, and inflammation

Speakers: Doctor D. Maeda, Doctor J. Vogel, Mr V. Ribeiro, Mr S. Decotto, Doctor J. Vogel...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources